Drug:
Reaction: GAIT DISTURBANCE
20260101 - 20261231
No. 1601 - 1700
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1601 | 26638779 |
EU |
78 | 1 |
Pneumonia, On and off phenomenon, Dysstasia, Gait disturbance, Speech disorder, Gait disturbance, Tremor, Poor quality sleep, Fear, Freezing phenomenon, Fatigue, Reduced facial expression, Psychiatric symptom, Dyskinesia, Bradykinesia, Dyskinesia, Catheter site bruise, Musculoskeletal stiffness, Muscle rigidity, Decreased appetite, Therapeutic product effect incomplete, Hallucination, Posture abnormal, Dizziness, Muscle discomfort, Mobility decreased, Freezing phenomenon, Abnormal dreams, Paranoia, Drug ineffective, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, SITAGLIPTIN, RASAGILINE MESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 1602 | 26638909 |
US |
67 | 2 |
Gait disturbance, Breast cancer, Thyroid disorder, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 1603 | 26639448 |
GB |
53 | 1 |
Myalgia, Gait disturbance, Drug intolerance, |
||||
IMATINIB, IMATINIB, DASATINIB, FOLIC ACID, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, ACYCLOVIR, SERTRALINE, CYANOCOBALAMIN, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, |
||||
| 1604 | 26634398 |
US |
72 | 2 |
Cataract, Rheumatoid arthritis, Condition aggravated, Ocular hyperaemia, Periorbital swelling, Essential hypertension, Balance disorder, Illness, Oedema peripheral, Asthenia, Gait disturbance, Bursitis, COVID-19, Intentional product misuse, |
||||
ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, PREDNISONE, DENOSUMAB, ZINC SULFATE, ZINC SULFATE INJECTION,, ZINC SULFATE INJECTION, ERGOCALCIFEROL, METHOTREXATE, METHOTREXATE SODIUM, ROSUVASTATIN CALCIUM, DIGOXIN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, FISH OIL, VITAMIN C, MAGNESIUM CARBONATE, |
||||
| 1605 | 26634429 |
CN |
22 | 2 |
Weight decreased, Disease recurrence, Paralysis, Off label use, Vomiting, Headache, Gait disturbance, Syncope, |
||||
BEVACIZUMAB, |
||||
| 1606 | 26634478 |
US |
64 | 1 |
Cerebrovascular accident, Paralysis, Paraplegia, Gait disturbance, Visual impairment, Hyporeflexia, Sensory loss, Chest discomfort, Paraesthesia, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, APALUTAMIDE, DAROLUTAMIDE, BACLOFEN, CALCIUM, CLOPIDOGREL, CLOPIDOGREL BISULFATE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, EZETIMIBE, IRON, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, PREGABALIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, |
||||
| 1607 | 26634533 |
GB |
74 | 1 |
Cerebrovascular accident, Inappropriate schedule of product administration, Hypoaesthesia, Balance disorder, Fall, Limb discomfort, Gait disturbance, Musculoskeletal chest pain, Productive cough, Feeling cold, Chromaturia, Confusional state, Malaise, Pyrexia, Decreased appetite, Neutrophil count abnormal, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CEPHALEXIN, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE, RIVAROXABAN, RIVAROXABAN, RIVAROXABAN, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, ACYCLOVIR, ACYCLOVIR, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, IXAZOMIB, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, |
||||
| 1608 | 26634717 |
US |
2 | |
Anxiety, Panic attack, Aphasia, Gait disturbance, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 1609 | 26634724 |
CA |
56 | 2 |
Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Arthropathy, Condition aggravated, Contraindicated product administered, Delirium, Diabetes mellitus, Diarrhoea, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug tolerance decreased, Fatigue, Fibromyalgia, Gait disturbance, Glossodynia, Grip strength decreased, Hand deformity, Hypersensitivity, Liver injury, Maternal exposure during pregnancy, Mobility decreased, Muscular weakness, Nausea, Oedema, Off label use, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Prescribed overdose, Prescribed underdose, Product use in unapproved indication, Product use issue, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Seronegative arthritis, Swelling, Synovitis, Systemic lupus erythematosus, Therapeutic product effect decreased, Treatment failure, Type 2 diabetes mellitus, Underdose, Upper respiratory tract infection, Urticaria, Visual impairment, Vomiting, Weight decreased, Weight increased, Wheezing, Wound infection, |
||||
TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, |
||||
| 1610 | 26634737 |
EU |
45 | 2 |
Gait disturbance, Brain fog, |
||||
LINAGLIPTIN, |
||||
| 1611 | 26634926 |
US |
84 | 1 |
Gait disturbance, Poor quality sleep, Balance disorder, Psychomotor hyperactivity, Nervousness, Insomnia, Brain fog, |
||||
LENALIDOMIDE, LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 1612 | 26635354 |
US |
55 | 2 |
Myalgia, Gait disturbance, Arthralgia, Pain, Pain in extremity, Neck pain, |
||||
RISANKIZUMAB-RZAA, |
||||
| 1613 | 26635485 |
EU |
27 | 2 |
Syncope, Weight increased, Myoclonic epilepsy, Derealisation, Nausea, Dizziness, Sensory disturbance, Pain, Asthenia, Fatigue, Muscle twitching, Pain, Feeling abnormal, Malaise, Gait disturbance, Swelling, Skin tightness, Skin striae, Hypotonia, Chest discomfort, Chest discomfort, Palpitations, Cognitive disorder, |
||||
OLANZAPINE, |
||||
| 1614 | 26635666 |
US |
2 | |
Pain, Pain in extremity, Chromaturia, Abdominal pain, Gait disturbance, |
||||
ELAFIBRANOR, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, AMMONIUM LACTATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LORATADINE, LORATADINE TABLET, EZETIMIBE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, PANTOPRAZOLE SODIUM, EVOLOCUMAB, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, URSODIOL, URSOSIOL, ALBUTEROL SULFATE, VITAMIN C, ERGOCALCIFEROL, ALPRAZOLAM, |
||||
| 1615 | 26635740 |
RU |
2 | |
Gait disturbance, |
||||
BOTULINUM TOXIN TYPE A, |
||||
| 1616 | 26635782 |
GB |
74 | 1 |
Cerebrovascular accident, Inappropriate schedule of product administration, Chromaturia, Confusional state, Decreased appetite, Balance disorder, Hypoaesthesia, Gait disturbance, Feeling cold, Fall, Limb discomfort, Malaise, Musculoskeletal chest pain, Neutrophil count abnormal, Productive cough, Pyrexia, |
||||
ACYCLOVIR, ACYCLOVIR, CEPHALEXIN, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, IXAZOMIB, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, RIVAROXABAN, RIVAROXABAN, RIVAROXABAN, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 1617 | 26636012 |
JP |
84 | 2 |
Fall, Gait disturbance, Femur fracture, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 1618 | 26636152 |
2 | ||
Menometrorrhagia, Gait disturbance, |
||||
ETONOGESTREL, |
||||
| 1619 | 26636169 |
US |
2 | |
Urinary tract infection, Mobility decreased, Gait disturbance, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 1620 | 26636217 |
US |
34 | 1 |
Off label use, Chronic kidney disease, Proteinuria, Acute kidney injury, Noninfective encephalitis, Seizure, Obesity, Lymphadenopathy, Acute kidney injury, Leukocytosis, Thrombocytopenia, Arthralgia, Headache, Diplopia, Irritable bowel syndrome, Asthma, Deafness, Meningitis aseptic, Tachycardia, Migraine, Neuralgia, Back pain, Intercostal neuralgia, Obstructive sleep apnoea syndrome, Anxiety, Blindness unilateral, Wound dehiscence, Glucose tolerance impaired, Sickle cell trait, Depression, Systemic inflammatory response syndrome, Gait disturbance, Pain, Spinal cord infection, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, DIVALPROEX SODIUM, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, GABAPENTIN, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, METHOCARBAMOL, METHOCARBAMOL TABLETS, MUPIROCIN, MUPIROCIN CALCIUM, NALOXONE, SUMATRIPTAN SUCCINATE, TOPIRAMATE, |
||||
| 1621 | 26636663 |
US |
40 | 2 |
Arthralgia, Gait disturbance, Hypocalcaemia, Influenza, Bronchitis, Paraesthesia, Product dose omission issue, |
||||
PALOPEGTERIPARATIDE, PALOPEGTERIPARATIDE, ERGOCALCIFEROL, ALPRAZOLAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, HYDROCHLOROTHIAZIDE, LISINOPRIL, MECLIZINE HCL 12.5 MG, MECLIZINE HCL 25 MG, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HCL 25MG, MECLIZINE HCL 12.5MG, VILOXAZINE HYDROCHLORIDE, TOPIRAMATE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 1622 | 26636672 |
US |
75 | 2 |
Dyspnoea exertional, Gait disturbance, Dyspnoea, |
||||
REMIBRUTINIB, LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, ATORVASTATIN CALCIUM, ALBUTEROL SULFATE, ALBUTEROL, PREDNISONE, |
||||
| 1623 | 26637007 |
US |
54 | 1 |
Gait disturbance, Condition aggravated, |
||||
IXEKIZUMAB, |
||||
| 1624 | 26637016 |
CA |
72 | 1 |
Pneumonia, Pruritus, Dysphonia, Gait disturbance, Urticaria, Paranasal sinus discomfort, Polyuria, Rhinorrhoea, Productive cough, Rash maculo-papular, Pain, Illness, Nasal congestion, Pyrexia, Viral infection, Sinus disorder, Inflammation, Decreased appetite, Rash, Headache, Aphonia, Sleep disorder, Pruritus, Drug hypersensitivity, Oropharyngeal pain, Erythema, Cough, Arthritis, |
||||
PREDNISONE, ETANERCEPT, IRBESARTAN, |
||||
| 1625 | 26637588 |
US |
76 | |
Neuropathy peripheral, Sinusitis, Somnolence, Feeling abnormal, Lethargy, Arthritis, Muscle atrophy, Gait disturbance, Off label use, |
||||
RUXOLITINIB, |
||||
| 1626 | 26637682 |
CA |
2 | |
Dementia, Gait disturbance, |
||||
ZOLEDRONIC ACID, |
||||
| 1627 | 26637935 |
CA |
52 | 2 |
Hypotension, Dizziness, Injection site erythema, Injection site urticaria, Gait disturbance, Injection site pruritus, Injection site mass, Pruritus, |
||||
FREMANEZUMAB-VFRM, CANDESARTAN, PROPRANOLOL HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, TOPIRAMATE, ONABOTULINUMTOXINA, |
||||
| 1628 | 26638028 |
57 | 2 | |
Palpitations, Muscle contractions involuntary, Anxiety, Blood potassium decreased, Drug hypersensitivity, Muscle strain, Gait disturbance, Arthralgia, Muscle tightness, Depression, |
||||
CIPROFLOXACIN HYDROCHLORIDE, METRONIDAZOLE, OMEPRAZOLE 20 MG, ERGOCALCIFEROL, |
||||
| 1629 | 26641689 |
70 | 1 | |
Intentional product use issue, Constipation, Gait disturbance, Nerve injury, Gait disturbance, Activities of daily living decreased, |
||||
ASCIMINIB, |
||||
| 1630 | 26642598 |
69 | 2 | |
Fall, Gait disturbance, |
||||
ABATACEPT, |
||||
| 1631 | 26628078 |
EU |
71 | 2 |
Diarrhoea, Arthralgia, Gait disturbance, Intestinal dilatation, Weight decreased, Diarrhoea, |
||||
ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, |
||||
| 1632 | 26628212 |
US |
74 | 2 |
Breast cancer female, Pulmonary artery occlusion, Face injury, Norovirus infection, Thrombosis, Bedridden, Gait disturbance, COVID-19, Visual impairment, Meningioma, Head injury, Fall, Urinary tract infection, Tremor, Calcinosis, Malaise, Lung disorder, Tooth fracture, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 1633 | 26628240 |
US |
2 | |
Neuropathy peripheral, Hallucination, Pneumonia, Hypersomnia, Gait disturbance, Balance disorder, Fall, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 1634 | 26628295 |
US |
1 | |
Gait disturbance, Movement disorder, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 1635 | 26628570 |
US |
||
Balance disorder, Gait disturbance, Urinary incontinence, |
||||
TEPROTUMUMAB, |
||||
| 1636 | 26628820 |
CO |
37 | 2 |
Near death experience, Upper-airway cough syndrome, Eye pain, Hypotension, Hyperhidrosis, Nasal congestion, Vomiting, Paraesthesia, Peripheral coldness, Rhinitis allergic, Oropharyngeal pain, Haemorrhage, Pain in extremity, Staphylococcal infection, Movement disorder, Blood pressure systolic abnormal, Respiratory disorder, Mean platelet volume abnormal, Blood glucose abnormal, Anxiety, Abdominal pain, Sinusitis, Throat irritation, Areflexia, Drug hypersensitivity, Blood pressure diastolic abnormal, Myalgia, Neuralgia, Cough, Nervous system disorder, Body dysmorphic disorder, Renal disorder, Infection parasitic, Nerve injury, Facial discomfort, Monocyte count increased, Nerve compression, Rhinorrhoea, Papilloma viral infection, Nasal turbinate hypertrophy, Injection site pain, Abdominal pain upper, Night sweats, Laryngitis, Nasal septum deviation, Chromaturia, Oropharyngeal plaque, Influenza, Choking, Facial pain, Neuropathy peripheral, Rebound effect, Dizziness, Lymphocyte count increased, Hyporeflexia, Pain in jaw, Creatine kinase abnormal, Blood pressure increased, Hypoglycaemia, Fatigue, Infection, Paranasal sinus abscess, Oedema peripheral, Oxygen saturation abnormal, Inflammation, Helicobacter infection, Urticaria, Headache, Blood pressure decreased, Menstrual disorder, Mean arterial pressure increased, Lymphadenopathy, Hypersensitivity, Neck pain, Thyroid disorder, Burns first degree, Lichen sclerosus, Dry mouth, Gait disturbance, Back pain, Blood potassium abnormal, Presyncope, Malaise, Pain, Stress, Influenza like illness, Dysphagia, Illness, Immunodeficiency, Palpitations, Asthenia, Stent-graft endoleak, Dyspnoea, Odynophagia, Electric shock sensation, Limb discomfort, Chest pain, Tachycardia, |
||||
DICLOFENAC, DICLOFENAC SODIUM, NITAZOXANIDE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, PREGABALIN, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, LOSARTAN, OXYGEN, 0XYGEN, |
||||
| 1637 | 26628843 |
JP |
8 | 2 |
Fatigue, Asthenia, Gait disturbance, Ataxia, Drug-disease interaction, Toxicity to various agents, |
||||
CLOZAPINE, LORAZEPAM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, APIXABAN, LANSOPRAZOLE, MAGNESIUM OXIDE, |
||||
| 1638 | 26628891 |
CA |
68 | 2 |
Joint stiffness, Joint swelling, Gait disturbance, Back pain, Arthralgia, Product substitution issue, |
||||
DENOSUMAB, |
||||
| 1639 | 26629160 |
US |
78 | 1 |
Gait disturbance, Arthropathy, |
||||
DUPILUMAB, |
||||
| 1640 | 26629174 |
US |
2 | |
Headache, Gait disturbance, Dyspnoea, Cough, |
||||
DUPILUMAB, CALCIUM, TEZEPELUMAB-EKKO, VITAMIN E, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 1641 | 26629199 |
CN |
85 | 1 |
Abdominal discomfort, Nausea, Vomiting, Dizziness, Blood pressure increased, Gait disturbance, |
||||
CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, |
||||
| 1642 | 26629551 |
US |
72 | 1 |
Pain, Gait disturbance, Activities of daily living decreased, |
||||
SARILUMAB, |
||||
| 1643 | 26629861 |
US |
1 | |
Pneumonia, Hepatic cirrhosis, Peripheral swelling, Platelet count decreased, Weight decreased, Splenomegaly, Gait disturbance, Muscle atrophy, Tremor, Drug ineffective, Therapy cessation, |
||||
AMIFAMPRIDINE PHOSPHATE, AMIFAMPRIDINE PHOSPHATE, HUMAN IMMUNOGLOBULIN G, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DOCUSATE SODIUM, DONEPEZIL HYDROCHLORIDE, DUTASTERIDE, HYDROXYUREA, LOSARTAN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, QUETIAPINE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, VALPROIC ACID, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, ERGOCALCIFEROL, DIVALPROEX SODIUM, |
||||
| 1644 | 26629941 |
US |
2 | |
Gait disturbance, |
||||
DUPILUMAB, |
||||
| 1645 | 26630044 |
US |
1 | |
Skin disorder, Condition aggravated, Gait disturbance, Scabies, Coronary arterial stent insertion, |
||||
DUPILUMAB, |
||||
| 1646 | 26630534 |
CA |
44 | 2 |
Wound infection, Abdominal pain, Abdominal pain upper, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthritis, Asthma, Autoimmune disorder, Blister, Bone erosion, Chest pain, Confusional state, Contusion, Crohn^s disease, Deep vein thrombosis postoperative, Diarrhoea, Discomfort, Dizziness, Dyspepsia, Dyspnoea, Exostosis, Fibromyalgia, Folliculitis, Gait disturbance, Gait inability, Grip strength decreased, Hepatic cirrhosis, Hypercholesterolaemia, Hypersensitivity, Impaired healing, Incorrect route of product administration, Infection, Infusion related reaction, Irritable bowel syndrome, Joint stiffness, Joint swelling, Laryngitis, Liver disorder, Lower limb fracture, Lupus vulgaris, Lupus-like syndrome, Memory impairment, Muscle injury, Muscular weakness, Musculoskeletal stiffness, Nasopharyngitis, Off label use, Pain, Pain in extremity, Peripheral swelling, Pneumonia, Prescribed underdose, Pruritus, Psoriasis, Pulmonary fibrosis, Pyrexia, Rash, Red blood cell sedimentation rate increased, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sleep disorder, Stomatitis, Synovitis, Systemic lupus erythematosus, Therapy non-responder, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, TRAMADOL HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, PREDNISONE, PREDNISONE, APREPITANT, APREPITANT, APREPITANT, APREPITANT, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, IODINE, LEFLUNOMIDE, LEFLUNOMIDE, PREGABALIN, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NEOMYCIN OINTMENT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, APREMILAST, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREGABALIN, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, LEFLUNOMIDE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIPROLIDINE HYDROCHLORIDE, CALCIUM CARBONATE, VITAMIN C, ERGOCALCIFEROL, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
| 1647 | 26630681 |
US |
48 | 1 |
Asthenia, Gait disturbance, Dyspnoea, Eczema, Rash, Pruritus, Skin burning sensation, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 1648 | 26630823 |
US |
73 | 2 |
Eczema, Pruritus, Arthralgia, Gait disturbance, |
||||
DUPILUMAB, DUPILUMAB, CETIRIZINE HYDROCHLORIDE, |
||||
| 1649 | 26631862 |
US |
62 | 2 |
Dizziness, Nausea, Gait disturbance, |
||||
DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, |
||||
| 1650 | 26631927 |
US |
43 | 2 |
Gait disturbance, Tremor, Hot flush, Paraesthesia, |
||||
BREMELANOTIDE, DIROXIMEL FUMARATE, |
||||
| 1651 | 26632158 |
US |
2 | |
Movement disorder, Nausea, Fatigue, Asthenia, Balance disorder, Therapeutic product effect incomplete, Bradykinesia, Nephropathy, Gait disturbance, |
||||
CARIPRAZINE, FLUOXETINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 1652 | 26632762 |
US |
68 | 2 |
Psoriatic arthropathy, Red blood cell sedimentation rate increased, Red cell distribution width increased, Monocyte count increased, Alanine aminotransferase increased, Synovitis, Joint effusion, Dactylitis, Grip strength decreased, Foot deformity, Drug ineffective, Overweight, Sacral pain, Gait disturbance, Trigger finger, Myalgia, Cervical radiculopathy, |
||||
APREMILAST, SULFASALAZINE, TIRZEPATIDE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, ALBUTEROL SULFATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, EMPAGLIFLOZIN, WARFARIN SODIUM, WARFARIN, EZETIMIBE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, DULOXETINE HYDROCHLORIDE, DULOXETINE, FLUCONAZOLE, ERGOCALCIFEROL, HYDROXYCHLOROQUINE SULFATE, FAMOTIDINE, PREDNISOLONE ACETATE, FEXOFENADINE HYDROCHLORIDE, ALBUTEROL SULFATE, AMLODIPINE, GABAPENTIN, |
||||
| 1653 | 26632783 |
US |
||
Gait disturbance, |
||||
LUMATEPERONE, LUMATEPERONE, |
||||
| 1654 | 26632848 |
CA |
||
Abdominal abscess, Dermatitis atopic, Gait disturbance, Discomfort, Off label use, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 1655 | 26633154 |
US |
2 | |
Gait disturbance, Balance disorder, |
||||
VALBENAZINE, VALBENAZINE, |
||||
| 1656 | 26633476 |
US |
||
Gastrointestinal disorder, Adverse drug reaction, Dysgraphia, Gallbladder disorder, Mental disorder, Dyspepsia, Gait disturbance, Headache, Arthralgia, Paralysis, Mobility decreased, Weight decreased, Chest discomfort, Vomiting, Diarrhoea, Impaired work ability, |
||||
ADALIMUMAB, |
||||
| 1657 | 26633541 |
US |
||
Somnolence, Gait disturbance, |
||||
ZURANOLONE, SERTRALINE, |
||||
| 1658 | 26633722 |
US |
||
Feeling abnormal, Product ineffective for unapproved use, Dizziness, Asthenia, Fatigue, Weight increased, Confusional state, Somnolence, Depressive symptom, Stress, General physical health deterioration, Hyperhidrosis, Quality of life decreased, Affect lability, Fluid retention, Depersonalisation/derealisation disorder, Gait disturbance, Aphasia, |
||||
BACLOFEN, CARBAMAZEPINE, OXCARBAZEPINE, |
||||
| 1659 | 26635798 |
90 | 2 | |
Performance status decreased, Tremor, Gait disturbance, Tremor, Nausea, |
||||
LENALIDOMIDE, |
||||
| 1660 | 26636231 |
75 | 2 | |
Diarrhoea, Joint stiffness, Gait disturbance, Fatigue, |
||||
CEFDINIR, LOSARTAN, MONTELUKAST SODIUM, MONTELUKAST, ERGOCALCIFEROL, |
||||
| 1661 | 26637066 |
63 | 2 | |
Hypoaesthesia, Blepharospasm, Neck pain, Hypoaesthesia, Muscle spasms, Asthenia, Hypoaesthesia, Gait disturbance, Hypomagnesaemia, Hypokalaemia, Hypoparathyroidism, Magnesium deficiency, Renal tubular dysfunction, |
||||
OLAPARIB, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PROCHLORPERAZINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SERTRALINE, MAGNESIUM, |
||||
| 1662 | 26622158 |
US |
82 | 2 |
Fall, Limb injury, Arthropathy, Gait disturbance, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 1663 | 26622316 |
EU |
82 | 2 |
Parkinsonism, Gait disturbance, |
||||
MIRABEGRON, |
||||
| 1664 | 26622479 |
US |
45 | |
Cerebrovascular accident, Brain oedema, Blindness unilateral, Hemiplegia, Menstrual clots, Heart rate increased, Heavy menstrual bleeding, Hypertension, Headache, Gait disturbance, Impaired work ability, |
||||
LEVONORGESTREL AND ETHINYL ESTRADIOL, LEVONORGESTREL AND ETHINYL ESTRADIOL, NAPROXEN, NAPROXEN SODIUM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LOSARTAN, |
||||
| 1665 | 26622556 |
EU |
2 | |
Neuropathy peripheral, Gait disturbance, |
||||
| 1666 | 26622659 |
EU |
58 | 2 |
Spinal fracture, Gait disturbance, Dyspnoea, Blood pressure increased, Malaise, Lumbar vertebral fracture, Thoracic vertebral fracture, |
||||
DENOSUMAB, DULOXETINE HYDROCHLORIDE, DULOXETINE, MIRTAZAPINE, VALPROATE SODIUM, LATANOPROST, ERGOCALCIFEROL, PHYTONADIONE, CALCIUM, MAGNESIUM, |
||||
| 1667 | 26623395 |
GB |
74 | 1 |
Inappropriate schedule of product administration, Balance disorder, Musculoskeletal chest pain, Decreased appetite, Cerebrovascular accident, Feeling cold, Fall, Malaise, Limb discomfort, Confusional state, Hypoaesthesia, Gait disturbance, Productive cough, Pyrexia, Neutrophil count abnormal, Chromaturia, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, IXAZOMIB, CEPHALEXIN, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, ACYCLOVIR, ACYCLOVIR, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, RIVAROXABAN, RIVAROXABAN, RIVAROXABAN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 1668 | 26623426 |
EC |
80 | 2 |
Breast cancer metastatic, Malignant neoplasm progression, Necrosis, Leukopenia, Neutropenia, Neuropathy peripheral, Lymphadenopathy, Anorectal herpes, Pulmonary mass, Bile duct stone, Bone lesion, Lymphadenopathy mediastinal, Uterine leiomyoma calcification, Hepatic lesion, Pleural effusion, Anorectal herpes, Muscle contracture, Gait disturbance, Urinary tract infection, Pain, Bladder disorder, Lymphocyte percentage decreased, Gamma-glutamyltransferase increased, Mean cell haemoglobin increased, Red cell distribution width increased, White blood cell count decreased, Red blood cell count decreased, Diverticulum, Haematocrit decreased, Blood glucose increased, Monocyte count increased, Anorectal disorder, Skin necrosis, |
||||
FULVESTRANT, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, SITAGLIPTIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, TELMISARTAN, BISOPROLOL FUMARATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, CALCIUM, ERGOCALCIFEROL, |
||||
| 1669 | 26623635 |
US |
2 | |
Cataract, Musculoskeletal disorder, Pain in extremity, Gait disturbance, |
||||
ETANERCEPT, |
||||
| 1670 | 26623718 |
US |
57 | 2 |
Gait disturbance, Arthralgia, |
||||
DUPILUMAB, |
||||
| 1671 | 26624300 |
GB |
74 | |
Inappropriate schedule of product administration, Cerebrovascular accident, Hypoaesthesia, Balance disorder, Confusional state, Fall, Malaise, Limb discomfort, Gait disturbance, Musculoskeletal chest pain, Productive cough, Feeling cold, Chromaturia, Pyrexia, Decreased appetite, Neutrophil count abnormal, |
||||
METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACYCLOVIR, ACYCLOVIR, IXAZOMIB, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, RIVAROXABAN, RIVAROXABAN, RIVAROXABAN, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, CEPHALEXIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 1672 | 26624397 |
CA |
75 | 2 |
Apraxia, Alopecia, Anaemia, Anxiety, Atrophic vulvovaginitis, Balance disorder, Bite, Blindness, Blood chloride decreased, Blood creatinine increased, Blood glucose decreased, Blood glucose increased, Blood iron decreased, Blood parathyroid hormone increased, Blood phosphorus increased, Blood potassium increased, Blood pressure decreased, Blood pressure fluctuation, Blood pressure increased, Blood pressure systolic increased, Blood sodium increased, Blood urea increased, Cholelithiasis, Chronic kidney disease, Confusional state, Decreased appetite, Dizziness, Dry skin, Erythema, Faeces discoloured, Fall, Fatigue, Gait disturbance, Haematocrit decreased, Haemoglobin decreased, Head injury, Headache, Heart rate irregular, Hepatic steatosis, Hyperglycaemia, Hypoglycaemia, Hypophagia, Inappropriate schedule of product administration, Insulin-like growth factor decreased, Joint swelling, Lethargy, Light chain analysis increased, Limb discomfort, Lymphocyte count decreased, Memory impairment, Muscle spasms, Muscular weakness, Nerve injury, Neuropathy peripheral, Nocturia, Osteoporosis, Paraesthesia, Peripheral swelling, Protein urine present, Pruritus, Pulmonary mass, Rash erythematous, Red blood cell count decreased, Skin discolouration, Sleep apnoea syndrome, Sleep disorder, Urethral caruncle, Urinary incontinence, Urine calcium/creatinine ratio increased, Vitamin B12 decreased, Weight decreased, White blood cell count decreased, Glycosylated haemoglobin increased, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, NICOTINAMIDE, CABERGOLINE, RISEDRONATE SODIUM, TELMISARTAN, LINAGLIPTIN, PYRIDOXINE HYDROCHLORIDE, |
||||
| 1673 | 26624538 |
CA |
54 | 2 |
Neuropathy peripheral, Dysstasia, Gait disturbance, Musculoskeletal stiffness, Pain in extremity, Diarrhoea, Fatigue, Nausea, |
||||
RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, |
||||
| 1674 | 26624570 |
US |
85 | 1 |
Balance disorder, Fall, Dizziness, Gait disturbance, Neuropathy peripheral, |
||||
DUPILUMAB, DONEPEZIL HYDROCHLORIDE, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ROSUVASTATIN CALCIUM, TADALAFIL, TAMSULOSIN HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ERGOCALCIFEROL, CETIRIZINE HYDROCHLORIDE, SILDENAFIL CITRATE, SILDENAFIL, |
||||
| 1675 | 26624690 |
CA |
2 | |
Near death experience, Gait disturbance, |
||||
SECUKINUMAB, |
||||
| 1676 | 26624778 |
US |
2 | |
Ankle operation, Fall, Gait disturbance, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 1677 | 26625067 |
US |
60 | 1 |
Pruritus, Gait disturbance, Vision blurred, Arthralgia, |
||||
DUPILUMAB, |
||||
| 1678 | 26625138 |
CA |
83 | 1 |
Dysuria, Gait disturbance, Back pain, Urinary tract infection, |
||||
DUPILUMAB, DUPILUMAB, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, DAPSONE GEL, 5%, DAPSONE, DASPONE, |
||||
| 1679 | 26625169 |
NI |
54 | 2 |
Retinal detachment, Blindness unilateral, Optic neuritis, Intraocular pressure increased, Blood pressure increased, Limb discomfort, Pain, Dizziness, General physical health deterioration, Gait disturbance, Stress, Balance disorder, Headache, Diplopia, |
||||
INTERFERON BETA-1A, |
||||
| 1680 | 26625474 |
US |
3 | 1 |
Disorientation, Confusional state, Tremor, Gait disturbance, Off label use, |
||||
CEPHALEXIN, |
||||
| 1681 | 26625614 |
US |
2 | |
Gait disturbance, Hypovitaminosis, Musculoskeletal pain, Arthralgia, Muscle atrophy, Electrolyte depletion, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 1682 | 26625639 |
US |
66 | 2 |
Hypersensitivity, Rash, Arthralgia, Gait disturbance, Oropharyngeal pain, Pyrexia, Lymph node pain, Odynophagia, Rhinorrhoea, Cough, Throat clearing, Nasal congestion, Fatigue, Asthenia, Dysphonia, Lymphadenopathy, Vomiting, Dyspnoea exertional, Nausea, Sinus disorder, Rhinitis, Psoriasis, Asthma, Bronchitis, Fibromyalgia, |
||||
APREMILAST, APREMILAST, APREMILAST, DENOSUMAB, DENOSUMAB, LATANOPROST, ZOLPIDEM TARTRATE, BENZONATATE, MONTELUKAST SODIUM, MONTELUKAST, DULOXETINE HYDROCHLORIDE, DULOXETINE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, PREDNISONE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREGABALIN, ALBUTEROL SULFATE, ALBUTEROL SULFATE, CYCLOSPORINE, BETAMETHASONE DIPROPIONATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, MELOXICAM, TIMOLOL MALEATE, TIMOLOL MALEATE OPHTHALMIC, PLECANATIDE, ERGOCALCIFEROL, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 1683 | 26626268 |
GB |
53 | 1 |
Myalgia, Gait disturbance, Drug intolerance, |
||||
IMATINIB, IMATINIB, DASATINIB, ACYCLOVIR, FOLIC ACID, SERTRALINE, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, CYANOCOBALAMIN, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 1684 | 26626305 |
US |
1 | |
Injection site erythema, Injection site swelling, Injection site pain, Dyspnoea, Gait disturbance, |
||||
GLATIRAMER ACETATE, GLATIRAMER ACETATE INJECTION, GLATIRAMER, GLATIRAMER ACETATE, GLATIRAMER ACETATE INJECTION, GLATIRAMER, |
||||
| 1685 | 26626502 |
US |
2 | |
Loss of personal independence in daily activities, Fall, Gait disturbance, |
||||
VALBENAZINE, |
||||
| 1686 | 26626616 |
US |
87 | 1 |
Gait disturbance, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 1687 | 26626628 |
2 | ||
Gait disturbance, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 1688 | 26627451 |
US |
62 | 2 |
Head injury, Road traffic accident, Back disorder, Mobility decreased, Post procedural infection, Off label use, Gait disturbance, |
||||
INSULIN LISPRO, TIRZEPATIDE, TIRZEPATIDE, INSULIN GLARGINE, |
||||
| 1689 | 26627631 |
JP |
74 | 1 |
Herpes zoster, Chronic kidney disease, Bladder catheterisation, Pain, Diabetes mellitus, Gait disturbance, |
||||
EVOLOCUMAB, |
||||
| 1690 | 26627754 |
US |
2 | |
Neoplasm malignant, Gait disturbance, |
||||
UPADACITINIB, |
||||
| 1691 | 26627784 |
EU |
82 | 2 |
Gait disturbance, Hypokinesia, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 1692 | 26616390 |
US |
2 | |
Blood iron decreased, Platelet count decreased, White blood cell count decreased, Full blood count decreased, Thyroid disorder, Alopecia, Dry skin, Gait disturbance, Drug ineffective, Fatigue, Asthenia, Anaemia, Somnolence, |
||||
RAVULIZUMAB, |
||||
| 1693 | 26616400 |
US |
1 | |
Atrial fibrillation, Autoimmune disorder, Gait disturbance, Hypertension, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 1694 | 26616475 |
US |
2 | |
Pneumonia respiratory syncytial viral, Product dose omission issue, Gait disturbance, Device use issue, Product delivery mechanism issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 1695 | 26616817 |
US |
66 | 2 |
Gait disturbance, Balance disorder, |
||||
INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, |
||||
| 1696 | 26616862 |
CA |
42 | 1 |
Gait disturbance, Arrhythmia, |
||||
OCRELIZUMAB, |
||||
| 1697 | 26616872 |
US |
60 | 2 |
Cerebral atrophy, Dysphagia, Bruxism, Sedation, Product prescribing error, Wrong technique in product usage process, Product use issue, Anxiety, Posture abnormal, Drug ineffective, Nervousness, Unresponsive to stimuli, Hypervigilance, Product dose omission issue, Gait disturbance, Product use in unapproved indication, |
||||
DEUTETRABENAZINE, DEUTETRABENAZINE, DEUTETRABENAZINE, DEUTETRABENAZINE, DEUTETRABENAZINE, DEUTETRABENAZINE, VALBENAZINE, |
||||
| 1698 | 26617025 |
US |
66 | 2 |
Dyspnoea, Myocardial infarction, Diabetic coma, Wrong technique in product usage process, Product packaging quantity issue, Blood potassium abnormal, Gait disturbance, |
||||
SODIUM ZIRCONIUM CYCLOSILICATE, |
||||
| 1699 | 26617175 |
US |
70 | 1 |
Metastases to spine, Illness, Gait disturbance, Muscular weakness, Therapy interrupted, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 1700 | 26617584 |
CA |
38 | 1 |
Syncope, Nasopharyngitis, Illness, Muscle tightness, Gait disturbance, Malaise, Product use issue, |
||||
INFLIXIMAB, INFLIXIMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
